期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

从2015美国糖尿病协会《糖尿病医学诊疗标准》看降糖药物治疗新进展 被引量：7

Update on hypoglycemic agent therapy in Standards of Medical Care in Diabetes(2015) published by ADA
原文传递
导出
摘要 美国糖尿病协会发表的2015《糖尿病医学诊疗标准》在2014版的基础上根据糖尿病领域最新的和最受关注的研究进展结果进行了修改。笔者将对该版诊疗标准中降糖药物治疗的更新内容做一简要解读,以便临床医师、药师了解2型糖尿病药物治疗的最新进展,对临床工作有所助益。 Standards of Medical Care in Diabetes- 2015＇ published by American Diabetes Association this year is an amendment of 2014 edition based on results from the latest and essential researches. This article intends to interpret the updates of pharmacotherapy for type 2 diabetes in this Standard, so as to be referred by clinicians and pharmacists.
作者 陆菊明
机构地区 解放军总医院内分泌科
出处 《临床药物治疗杂志》 2015年第4期1-4,共4页 Clinical Medication Journal
关键词 糖尿病 糖尿病医学诊疗标准 药物治疗 diabetes mellitus Standards of Medical Care in Diabetes medication
分类号 R977.15 [医药卫生—药品]
  • 相关文献

参考文献16

  • 1Federation International Diabetes,IDF Diabetes Atlas[M].6th ed.2013:Brussels,Belgium:International Diabetes Federation.
  • 2Association American Diabetes,Standards of Medical Care in Diabetes—2015[J].Diabetes Care,2015,38(Suppl1):S1-S2.
  • 3Deacon C F.Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes:a comparative review[J].Diabetes Obes Metab,2011.13(1):7-18.
  • 4Baetta R,Corsini A.Pharmacology of dipeptidyl peptidase-4inhibitors:similarities and differences[J].Drugs,2011.71(11):1441-1467.
  • 5Scheen A J,Paquot N.Gliptin versus a sulphonylurea as add-on to metformin[J].Lancet,2012,380(9840):450-452.
  • 6Esposito K,Chiodini P,Capuano A,et al.Baseline glycemic parameters predict the hemoglobin A1c response to DPP-4 inhibitors:metaregression analysis of 78 randomized controlled trials with 20,053patients[J].Endocrine,2014,46(1):43-51.
  • 7Scirica B M,Bhatt D L,Braunwald E,et al.Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus[J].N Engl J Med,2013,369(14):1317-1326.
  • 8White W B,Cannon C P,Heller S R,et al.Alogliptin after acute coronary syndrome in patients with type 2 diabetes[J].N Engl J Med,2013,369(14):1327-1335.
  • 9.Green J B,Bethel M A,Armstrong P W,et al.Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes[J].N Engl J Med,2015[Epub ahead of print].
  • 10Umpierrez G E,Gianchandani R,Smiley D,et al.Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes:a pilot,randomized,controlled study[J].Diabetes Care,2013,36(11):3430-3435.

同被引文献99

  • 1中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中国肝脏病杂志（电子版）,2010,2(4):43-48. 被引量：470
  • 2马念章,李光,廖静敏.人体内酮体检测技术的研究进展[J].分析化学,2005,33(7):1019-1022. 被引量：14
  • 3李宁,贾明.老年糖尿病酮症酸中毒68例临床分析[J].陕西医学杂志,2006,35(3):358-359. 被引量：3
  • 4王瑞涛,高兴强,艾尔肯.注意防范老年糖尿病酮症酸中毒误诊[J].临床误诊误治,2007,20(6):27-27. 被引量：4
  • 5Dacosta DA.Longitudinal assessment of painful diabetic peripheral neruopathy on health status,productivity,and health care utilization and cost.Pain Med,2011,12:118-126.
  • 6Abhary S,Burdon KP,Laurie KJ,et al.Aldose reductase gene polymorphisms and diabetic retionpathy susceptibility.Diabetes Care,2010,33:1834-1836.
  • 7International Diabetes Federation. IDF Diabetes Atlas~R/ OL~. 6th ed. IDF,2013. E2016-05-30]. http://www, dia- betesatlas, org/resourees/previous-editions, html.
  • 8Association American Diabetes. Standards of medical care in diabetes-2015EJ~. Diabetes Care, 2015,38 ( 11 ) : 1 2.
  • 9Inzueehi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study o{ Diabetes (EASD) EJ ]. Diabetologia, 2012,55 ( 6 ) : 1577 1596.
  • 10伊遥.DPPIV抑制剂的幸福时光[N].医药经济报,201208—3l[2016—05—30].http://www.yyjjb.com.cn/html/201208/31/content—175209.htm.

引证文献7

二级引证文献71

临床药物治疗杂志
2015年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部